Product Information
BUMETANIDE 2 MG TABLET is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.1749 per EA under NDC 51672422501. Its NADAC has been published 126 times since Jan 31, 2024.
Strength
2 mg/1
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672422501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUMETANIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213458On Market Since
7/24/2023
Pharmacological Classes
Price Statistics
The NADAC for BUMETANIDE 2 MG TABLET has been published 126 times since Jan 31, 2024, and over the history we have for it it has declined 43.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1749 per EA |
|---|---|
| All-time high | $0.3271 (Jul 10, 2024) |
| All-time low | $0.1749 (Jun 17, 2026) |
| 52-week high | $0.2544 |
| 52-week low | $0.1749 |
| Median price | $0.2436 |
| Average price | $0.2431 |
| Largest weekly change | +35.6% (Jun 19, 2024) |
| Weeks tracked | 126 |
| Tracking since | Jan 31, 2024 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUMETANIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 2 MG TABLET, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.1749 per EA (NDC 51672422501), effective Jun 24, 2026.
How has the price of BUMETANIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUMETANIDE 2 MG TABLET has declined 43.3%. It has been tracked across 126 weekly CMS publications since Jan 31, 2024.
What are the highest and lowest recorded NADAC prices for BUMETANIDE 2 MG TABLET?
Since Jan 31, 2024, the NADAC for BUMETANIDE 2 MG TABLET has ranged from a low of $0.1749 (Jun 17, 2026) to a high of $0.3271 (Jul 10, 2024), with a median of $0.2436 per EA.
Are there cheaper alternatives to BUMETANIDE 2 MG TABLET?
8 NADAC-published products share the same active ingredient, strength, and dosage form as BUMETANIDE 2 MG TABLET, but none are currently priced below it.
Who manufactures BUMETANIDE 2 MG TABLET?
BUMETANIDE 2 MG TABLET (NDC 51672422501) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification